Hostname: page-component-76d6cb85b7-xh428 Total loading time: 0 Render date: 2026-07-27T20:33:55.159Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute epiglottitis: epidemiology and Streptococcus pneumoniae serotype distribution in adults

Published online by Cambridge University Press:  25 November 2010

M Isakson  and
S Hugosson
M Isakson
Affiliation:
Department of Otolaryngology, Örebro University Hospital, Sweden
S Hugosson*
Affiliation:
Department of Otolaryngology, Örebro University Hospital, Sweden
*
Address for correspondence: Dr Svante Hugosson, Dept of Otolaryngology, Örebro University Hospital, SE-701 85 Örebro, Sweden Fax: +46 19 10 33 01 E-mail: svante.hugosson@orebroll.se
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

We studied the incidence and bacterial epidemiology of acute epiglottitis presenting in the first 16 years following the introduction of general childhood vaccination against Haemophilus influenzae type b. Our main objectives were to analyse (1) the incidence of Streptococcus pneumoniae epiglottitis in adults and (2) the distribution of pneumococcal serotypes involved.

Materials and methods:

The medical records of patients with acute epiglottitis (International Classification of Disease code J05.1) were investigated. Streptococcus pneumoniae serotyping was performed using gel precipitation.

Results:

The overall incidence of acute epiglottitis was 0.98 cases/100 000/year, compared with 4.5 cases/100 000/year before the vaccination programme. The incidence was reduced both in children and adults, compared with pre-vaccination values. However, the incidence of Streptococcus pneumoniae epiglottitis in adults increased from 0.1 to 0.28 cases/100 000/year over the same time period. The causative agent was Streptococcus pneumoniae in 10 adults. Nine of 10 pneumococcal strains could be serotyped. All but one serotype is represented in the 23-valent pneumococcal polysaccharide vaccine (PPV23) used in adults.

Conclusion:

In acute epiglottitis, now a disease of adults, the most important bacterial aetiology is Streptococcus pneumoniae. The serotype distribution found in this study indicates that the infection is preventable by PPV-23 vaccination with the 23-valent polysaccharide vaccine.

Keywords

EpiglottitisEpidemiologyStreptococcus PneumoniaeVaccination

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 125 , Issue 4 , April 2011 , pp. 390 - 393
Copyright
Copyright © JLO (1984) Limited 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1MayoSmith, MF, Hirsch, PJ, Wodzinski, SF, Schiffman, FJ. Acute epiglottitis in adults. An eight-year experience in the state of Rhode Island. N Engl J Med 1986;314:1133–9CrossRefGoogle ScholarPubMed
2Guldfred, LA, Lyhne, D, Becker, BC. Acute epiglottitis: epidemiology, clinical presentation, management and outcome. J Laryngol Otol 2008;122:818–23CrossRefGoogle ScholarPubMed
3Hugosson, S, Olcén, P, Ekedahl, C. Acute epiglottitis – aetiology, epidemiology and outcome in a population before large-scale Haemophilus influenzae type b vaccination. Clin Otolaryngol 1994;19:441–5CrossRefGoogle Scholar
4Trollfors, B, Nylén, O, Strangert, K. Acute epiglottitis in children and adults in Sweden 1981–83. Arch Dis Childhood 1990;65:491–4CrossRefGoogle Scholar
5Isakson, M, Hugosson, S. Acute epiglottitis now affecting adults is mainly caused by pneumococci. Important to observe the incidence when considering future vaccination strategy [in Swedish]. Akut epiglottit: nu vuxensjukdom främst orsakad av pneumokocker 2007;104:3531–3Google ScholarPubMed
6Statistics, Sweden [in Swedish]. In: http://www.scb.se [18 February 2010]Google Scholar
7Wood, N, Menzies, R, McIntyre, P. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease. Internal Medicine Journal 2005;35:530–5CrossRefGoogle ScholarPubMed
8Bogaert, D, Hermans, PW, Adrian, PV, Rümke, HC, de Groot, R. Pneumococcal vaccines: an update on current strategies. Vaccine 2004;22:2209–20CrossRefGoogle ScholarPubMed
9Moberley, SA, Holden, J, Andrews, R, Tatham, D. Vaccines preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422CrossRefGoogle ScholarPubMed
10Trollfors, B, Nylén, O, Carenfelt, C, Fogle-Hansson, M, Freijd, A, Geterud, Å et al. Aetiology of acute epiglottitis in adults. Scand J Infect Dis 1998;30:49–51CrossRefGoogle ScholarPubMed
11Garpenholt, Ö, Hugosson, S, Fredlund, H, Giesecke, J, Olcén, P. Invasive disease due to Haemophilus influenzae type b during the first six years of general vaccination of Swedish children. Acta Paediatr 2000;89:471–4CrossRefGoogle ScholarPubMed
12McEwan, J, Giridharan, W, Clarke, R, Shears, P. Paediatric acute epiglottitis: not a disappearing entity. Int J Ped Otorhinolaryngol 2003;67:317–21CrossRefGoogle Scholar
13Mühlemann, K, Alexander, ER, Pepe, M, Weiss, N, Schopfer, K, the Swiss Haemophilus influenzae study group. Invasive Haemophilus influenzae disease and epiglottitis among Swiss children from 1980 to 1993: evidence for herd immunity among older age groups. Scand J Infect Dis 1996;28:265–8CrossRefGoogle ScholarPubMed